Doxycycline Post-Exposure Prophylaxis Knowledge, Attitudes, and Practices Among HIV and PrEP Providers in Two NYC Academic Medical Centers: A Cross-Sectional Pilot Survey

BACKGROUND: Doxycycline post-exposure prophylaxis (doxy-PEP) reduces sexually transmitted infections (STIs) among vulnerable populations. Effective implementation depends on willingness to prescribe, yet data on provider knowledge, attitudes, and practices in New York City (NYC) remain limited. METHODS: We conducted a cross-sectional survey of providers at two NYC academic medical centers between May-September 2025. Eligibility required prescribing antiretroviral therapy or PrEP (pre-exposure prophylaxis) to ≥ 5 patients in the prior year. The online questionnaire adapted from a PrEP acceptability instrument measured provider doxy-PEP knowledge, attitudes, prescribing practices, and perceived barriers. Knowledge scores were summed from correct responses; attitudes on a 4-point Likert scale were transformed to reflect positive views and summed. Median total scores were compared between primary care (non-specialists) and Infectious Disease/HIV (specialists) providers using one-sided Mann-Whitney U-tests to assess whether non-specialists had lower knowledge and attitude scores. Prescribing practices were compared with Fisher's exact test. RESULTS: Thirty-eight eligible providers completed the survey (28 specialists, 10 non-specialists); 97% prescribed doxy-PEP previously. Specialists managed significantly larger HIV/PrEP patient panels (p<0.01). Non-specialists demonstrated lower objective doxy-PEP knowledge than specialists (median composite score 57% vs 86%, p < 0.01), particularly regarding efficacy and dosing. Doxy-PEP attitudes were favorable in both groups (median composite score 3.3 vs 3.4, max 4, p = 0.05). Concerns about antimicrobial resistance (49%) and side effects (30%) were the most reported prescribing barriers. CONCLUSIONS: Non-specialists endorsed favorable doxy-PEP attitudes but had lower objective knowledge. Barriers including resistance and adverse effects highlight opportunities for targeted education to improve doxy-PEP knowledge and prescribing confidence among generalist providers.

Authors

Institutions

Publication Details

Journal
Sexually Transmitted Diseases
Published
2026-11-17
DOI
https://doi.org/10.1097/olq.0000000000002450
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Doxycycline Post-Exposure Prophylaxis Knowledge, Attitudes, and Practices Among HIV and PrEP Providers in Two NYC Academic Medical Centers: A Cross-Sectional Pilot Survey

Yotam Arens, Jason E Zucker, Cecilia Yoon
9 links
Sexually Transmitted Diseases
HIV/AIDS Research and Interventions
article

Doxycycline Post-Exposure Prophylaxis Knowledge, Attitudes, and Practices Among HIV and PrEP Providers in Two NYC Academic Medical Centers: A Cross-Sectional Pilot Survey

Yotam Arens, Jason E Zucker, Cecilia Yoon
article en

Abstract

BACKGROUND: Doxycycline post-exposure prophylaxis (doxy-PEP) reduces sexually transmitted infections (STIs) among vulnerable populations. Effective implementation depends on willingness to prescribe, yet data on provider knowledge, attitudes, and practices in New York City (NYC) remain limited. METHODS: We conducted a cross-sectional survey of providers at two NYC academic medical centers between May-September 2025. Eligibility required prescribing antiretroviral therapy or PrEP (pre-exposure prophylaxis) to ≥ 5 patients in the prior year. The online questionnaire adapted from a PrEP acceptability instrument measured provider doxy-PEP knowledge, attitudes, prescribing practices, and perceived barriers. Knowledge scores were summed from correct responses; attitudes on a 4-point Likert scale were transformed to reflect positive views and summed. Median total scores were compared between primary care (non-specialists) and Infectious Disease/HIV (specialists) providers using one-sided Mann-Whitney U-tests to assess whether non-specialists had lower knowledge and attitude scores. Prescribing practices were compared with Fisher's exact test. RESULTS: Thirty-eight eligible providers completed the survey (28 specialists, 10 non-specialists); 97% prescribed doxy-PEP previously. Specialists managed significantly larger HIV/PrEP patient panels (p<0.01). Non-specialists demonstrated lower objective doxy-PEP knowledge than specialists (median composite score 57% vs 86%, p < 0.01), particularly regarding efficacy and dosing. Doxy-PEP attitudes were favorable in both groups (median composite score 3.3 vs 3.4, max 4, p = 0.05). Concerns about antimicrobial resistance (49%) and side effects (30%) were the most reported prescribing barriers. CONCLUSIONS: Non-specialists endorsed favorable doxy-PEP attitudes but had lower objective knowledge. Barriers including resistance and adverse effects highlight opportunities for targeted education to improve doxy-PEP knowledge and prescribing confidence among generalist providers.

Sexually Transmitted Diseases
Columbia University Irving Medical Center (US), Weill Cornell Medicine (US)
Good health and well-being
HIV/AIDS Research and Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon